Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers 2020-10-05 18:00
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer 2020-10-01 22:00
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
ILIAS Biologics Closes $20.6 Million Series B Financing 2020-09-28 19:00
World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs 2020-09-28 19:00
Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020 2020-09-28 18:00
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA 2020-09-25 10:37
KYAN Therapeutics Exclusively Licenses Small Molecule HDAC Inhibitors for AI-Powered Cancer Drug Development 2020-09-24 17:12
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau 2020-09-23 15:00
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio 2020-09-23 09:00
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply 2020-09-22 07:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. 2020-09-17 22:00
Samsung Biologics signs development agreement with Panolos for solid tumor treatment 2020-09-17 08:43
Less is more: Novel algorithm automatically removes poor-quality data to improve AI scalability 2020-09-16 22:50
Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy 2020-09-15 23:00
PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020 2020-09-14 20:00
NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients 2020-09-11 20:55
CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership 2020-09-10 20:08
1 122 123 124 125 126 227